| Christopher B Gilbert, MD | |
|
701 Ostrum St, Suite 203, Fountain Hill, PA 18015-1155 | |
| (610) 691-3603 | |
| (610) 861-8104 |
| Full Name | Christopher B Gilbert |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 701 Ostrum St, Fountain Hill, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790885119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD0633064L (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| Star Community Health Inc | 7618215237 | 32 |
News Archive
Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).
Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.
A poll of 2,000 gym-goers revealed adults will hit the gym to keep up with friends but in doing so they fall foul and treat a simple fitness session as a competition.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).
India's 2011 census data show that "wealthier, better-educated families," who have a first-born daughter "are choosing more and more often to abort subsequent pregnancies if the child is female," despite fetal sex determination and sex-selective abortion being illegal in the country, according to a study published on Tuesday in the Lancet, National Journal reports.
› Verified 9 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).
Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.
A poll of 2,000 gym-goers revealed adults will hit the gym to keep up with friends but in doing so they fall foul and treat a simple fitness session as a competition.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).
India's 2011 census data show that "wealthier, better-educated families," who have a first-born daughter "are choosing more and more often to abort subsequent pregnancies if the child is female," despite fetal sex determination and sex-selective abortion being illegal in the country, according to a study published on Tuesday in the Lancet, National Journal reports.
› Verified 9 days ago
| Entity Name | Star Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).
Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.
A poll of 2,000 gym-goers revealed adults will hit the gym to keep up with friends but in doing so they fall foul and treat a simple fitness session as a competition.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).
India's 2011 census data show that "wealthier, better-educated families," who have a first-born daughter "are choosing more and more often to abort subsequent pregnancies if the child is female," despite fetal sex determination and sex-selective abortion being illegal in the country, according to a study published on Tuesday in the Lancet, National Journal reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher B Gilbert, MD 701 Ostrum St, Suite 203, Fountain Hill, PA 18015-1155 Ph: (610) 691-3603 | Christopher B Gilbert, MD 701 Ostrum St, Suite 203, Fountain Hill, PA 18015-1155 Ph: (610) 691-3603 |
News Archive
Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).
Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.
A poll of 2,000 gym-goers revealed adults will hit the gym to keep up with friends but in doing so they fall foul and treat a simple fitness session as a competition.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).
India's 2011 census data show that "wealthier, better-educated families," who have a first-born daughter "are choosing more and more often to abort subsequent pregnancies if the child is female," despite fetal sex determination and sex-selective abortion being illegal in the country, according to a study published on Tuesday in the Lancet, National Journal reports.
› Verified 9 days ago
Dr. Elizabeth Linda Dierking, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 203, Fountain Hill, PA 18015 Phone: 610-691-3603 Fax: 610-861-8104 | |
Joseph G. Bell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 303, Fountain Hill, PA 18015 Phone: 610-954-3900 Fax: 610-954-3908 | |
Dr. Meredith L. Birsner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St Ste 303, Fountain Hill, PA 18015 Phone: 484-526-3900 Fax: 484-526-3908 | |
Kristin Abbruzzi, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 685 Delaware Ave, Fountain Hill, PA 18015 Phone: 610-867-4151 Fax: 610-867-9129 | |
Joseph C.l. Merola, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 701 Ostrum St, Suite 203, Fountain Hill, PA 18015 Phone: 610-691-3603 Fax: 610-861-8104 | |
Valerie J. Riley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 102, Fountain Hill, PA 18015 Phone: 610-954-4960 Fax: 610-954-3162 | |
Christopher Wayock, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 701 Ostrum St, Suite 303, Fountain Hill, PA 18015 Phone: 484-526-3900 Fax: 484-526-3908 |